Naturally, the third component of the ECS system, i.e., endocannabinoids and enzymes responsible for the metabolism of endocannabinoids (FAAH and MAGL), is also important in the context of schizophrenia-like effects [15, 22]. The gene discussed is MGLL; the disease is schizophrenia.